or Try an Advanced Search...

    Lymphocytic Leukemia Stocks List

    Symbol Grade Name % Change
    AFMD D Affimed Therapeutics B.V. 1.87
    BIIB D Biogen Idec Inc. -2.24
    CLLS C Cellectis S.A. -0.66
    EBS C Emergent Biosolutions, Inc. -7.71
    EGRX F Eagle Pharmaceuticals, Inc. 3.04
    GMAB D Genmab A/S -1.89
    LGND C Ligand Pharmaceuticals Incorporated -0.87
    TEVA C Teva Pharmaceutical Industries -2.86
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20

    Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

    Symbol Grade Name Weight
    ISRA C Market Vectors Israel ETF 10.02
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 9.21
    PJP A PowerShares Dynamic Pharmaceuticals 7.29
    FBT C First Trust Amex Biotech Index Fund 6.92
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.31
    View all Lymphocytic Leukemia ETFs...
    Compare ETFs
    Compare EIS to BIS Compare ISRA to EIS Compare PJP to BIS

        Lymphocytic Leukemia Stocks Recent News

        Date Stock Title
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 LGND Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
        May 16 LGND Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 LGND Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 EBS Walgreens launches its own opioid reversal therapy for OTC use
        May 15 LGND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 GMAB Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 TEVA Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20
        Lymphocytic Leukemia

        Lymphocytic leukemia is a type of cancer that affects the white blood cells, or lymphocytes, in the body. It is a type of leukemia, which is a cancer of the blood and bone marrow. In lymphocytic leukemia, the body produces too many abnormal lymphocytes, which can crowd out healthy white blood cells, red blood cells, and platelets. This can lead to anemia, infections, and other serious health problems. Treatment for lymphocytic leukemia typically involves chemotherapy, radiation, and/or stem cell transplant.

        Browse All Tags